Direct admission of stroke in MRI room reduces in-hospital delays and improves recovery.


Journal

Revue neurologique
ISSN: 0035-3787
Titre abrégé: Rev Neurol (Paris)
Pays: France
ID NLM: 2984779R

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 28 06 2021
revised: 23 12 2021
accepted: 21 03 2022
pubmed: 20 7 2022
medline: 29 11 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

Efficacy of intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) is strongly time dependent in acute stroke management. We investigated the impact of a direct magnetic resonance imaging (MRI) room admission protocol in order to reduce in-hospital delays. We implemented a protocol of direct MRI room admission, bypassing the Emergency Department. We compared in-hospital delays, clinical and functional outcomes using National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) scores, between patients hospitalized via this protocol and those admitted via the standard workflow and treated by IVT and/or MT. The primary endpoint was the proportion of patients with door-to-needle time (DTN) ≤ 60minutes. Among 308 consecutive patients included, 62 underwent direct MRI room admission. The proportion of patients with DTN ≤ 60minutes was higher in the intervention group compared to the control group (82.5% vs. 17.8%, P<0.001), and median DTN was lower (45min vs. 75min, P<0.001). Despite a functional benefit at discharge on dichotomized mRS (mRS [0-2, as independence]: 66.1% vs. 51.2%, P=0.003), the difference was no longer statistically significant at six months (68.4% vs. 57.4%, P=0.10). Direct MRI room admission of stroke alerts is associated with an important reduction of treatment times and improves functional outcomes.

Identifiants

pubmed: 35851486
pii: S0035-3787(22)00648-8
doi: 10.1016/j.neurol.2022.03.021
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

969-974

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

L Legris (L)

Neurology department, Grenoble Alpes university hospital, 38043 Grenoble, France. Electronic address: llegris@chu-grenoble.fr.

S Grand (S)

Neuroradiology department, Grenoble Alpes university hospital, 38043 Grenoble, France.

M Roustit (M)

Clinical pharmacology, Inserm CIC1406, Grenoble Alpes university hospital, 38043 Grenoble, France.

V Brenckmann (V)

Emergency department, Grenoble Alpes university hospital, 38043 Grenoble, France.

I Favre-Wiki (I)

Neurology department, Grenoble Alpes university hospital, 38043 Grenoble, France.

O Detante (O)

Neurology department, Grenoble Alpes university hospital, 38043 Grenoble, France.

J Papassin (J)

Neurology department, Chambéry-Métropole-Savoie hospital, 73000 Chambéry, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH